Stage IVA Bladder Cancer AJCC v8
| Drug | Drug Name | Drug Description |
|---|
| Drug | Drug Name | Target | Type |
|---|
| Drug | Drug Name | Phase | Status | Count |
|---|---|---|---|---|
| DB02379 | Beta-D-Glucose | 1 | Completed | 1 |
| DB00958 | Carboplatin | 1 | Completed | 1 |
| DB14547 | Chloride ion | 1 | Completed | 1 |
| DB00515 | Cisplatin | 1 | Completed | 1 |
| DB01248 | Docetaxel | 1 | Completed | 1 |
| DB00773 | Etoposide | 1 | Completed | 1 |
| DB09037 | Pembrolizumab | 1 | Completed | 1 |
| DB12257 | Platinum | 1 | Completed | 1 |
| DB11595 | Atezolizumab | 1 / 2 | Recruiting | 1 |
| DB11945 | Avelumab | 1 / 2 | Recruiting | 1 |
| DB11714 | Durvalumab | 1 / 2 | Recruiting | 1 |
| DB09035 | Nivolumab | 1 / 2 | Recruiting | 1 |
| DB09037 | Pembrolizumab | 1 / 2 | Recruiting | 1 |
| DB05992 | Plinabulin | 1 / 2 | Recruiting | 1 |
| DB11595 | Atezolizumab | 2 | Active Not Recruiting | 1 |
| DB11595 | Atezolizumab | 2 | Withdrawn | 1 |
| DB11714 | Durvalumab | 2 | Active Not Recruiting | 1 |
| DB12147 | Erdafitinib | 2 | Withdrawn | 1 |
| DB11997 | Interleukin-7 | 2 | Active Not Recruiting | 1 |
| DB09035 | Nivolumab | 2 | Recruiting | 1 |
| DB14851 | Relatlimab | 2 | Recruiting | 1 |
| DB11771 | Tremelimumab | 2 | Active Not Recruiting | 1 |
| DB01248 | Docetaxel | 3 | Recruiting | 1 |
| DB08871 | Eribulin | 3 | Recruiting | 1 |
| DB00441 | Gemcitabine | 3 | Recruiting | 1 |
| DB01229 | Paclitaxel | 3 | Recruiting | 1 |
| DB12893 | Sacituzumab govitecan | 3 | Recruiting | 1 |